PMBPX
Price
$45.90
Change
+$0.37 (+0.81%)
Updated
Jul 16 closing price
Net Assets
31.8B
RSDGX
Price
$21.81
Change
+$0.11 (+0.51%)
Updated
Jul 16 closing price
Net Assets
82.71M
Interact to see
Advertisement

PMBPX vs RSDGX

Header iconPMBPX vs RSDGX Comparison
Open Charts PMBPX vs RSDGXBanner chart's image
Principal MidCap R5
Price$45.90
Change+$0.37 (+0.81%)
VolumeN/A
Net Assets31.8B
Victory RS Select Growth A
Price$21.81
Change+$0.11 (+0.51%)
VolumeN/A
Net Assets82.71M
PMBPX vs RSDGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMBPX vs. RSDGX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBPX is a Buy and RSDGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 31.8B vs. RSDGX (82.7M). PMBPX pays higher dividends than RSDGX: PMBPX (0.01) vs RSDGX (0.00). PMBPX was incepted earlier than RSDGX: PMBPX (25 years) vs RSDGX (29 years). RSDGX (1.53) is less costly to investors than PMBPX (0.83). RSDGX is a more actively managed with annual turnover of: 129.00 vs. PMBPX (10.50). PMBPX has a lower initial minimum investment than RSDGX: PMBPX (0) vs RSDGX (2500). PMBPX annual gain was more profitable for investors over the last year : 7.64 vs. RSDGX (2.94). PMBPX return over 5 years is better than : 51.07 vs. RSDGX (-41.13).
PMBPXRSDGXPMBPX / RSDGX
Total Expense Ratio0.831.4059%
Annual Report Gross Expense Ratio0.831.5354%
Fund Existence25 years29 years-
Gain YTD4.763-4.447-107%
Front LoadN/A6%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets31.8B82.7M38,452%
Annual Yield % from dividends0.010.00-
Returns for 1 year7.642.94260%
Returns for 3 years48.512.312,100%
Returns for 5 years51.07-41.13-124%
Returns for 10 years96.92-58.17-167%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATRA9.280.01
+0.11%
Atara Biotherapeutics Inc.
BB4.04-0.03
-0.74%
BlackBerry Limited
CCLDO19.60-0.41
-2.05%
CareCloud
ARCT12.85-0.30
-2.28%
Arcturus Therapeutics Holdings
UFPI101.81-2.98
-2.84%
UFP Industries